From Nonconformities to Insight: Leveraging Biocompatibility Assessment Trends for Regulatory Intelligence and Strategic Compliance

Description: As regulatory expectations for biocompatibility evolve—particularly under the EU Medical Device Regulation (MDR) and U.S. FDA frameworks—manufacturers face mounting challenges in aligning biological evaluations with global regulatory and scientific standards.
This presentation draws from a comprehensive analysis of over 100 biocompatibility assessments conducted by a Notified Body, offering a data-driven perspective on recurring nonconformities and compliance pitfalls observed across diverse product submissions. Rather than developing a performance scoring model, the focus was on systematically identifying patterns, root causes, and process-level vulnerabilities that compromise regulatory success.
Attendees will gain insight into how this classification of findings can inform the development of regulatory intelligence metrics and key performance indicators (KPIs). The session will explore how cross-functional teams—from regulatory affairs to R&D and quality—can use these insights to strengthen proactive compliance strategies, enhance dossier readiness, and improve biocompatibility planning from the early stages of product development.
Ultimately, the session will demonstrate how trend analysis of biocompatibility reviews can move organizations from reactive remediation to strategic foresight.